Roberto Papait
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Roberto Papait has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Gianluigi Condorelli
Department of Biomedical Sciences, Humanitas University , 20072 Pieve Emanuele, Milan
15 shared publications - Christina Pagiatakis
Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy
12 shared publications - Rosalba Gornati
Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy
9 shared publications - Simone Serio
IRCCS Humanitas Research Hospital, Rozzano, Italy (S.S.).
9 shared publications - Giovanni Bernardini
Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy
8 shared publications - Paolo Kunderfranco
Bioinformatics Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
8 shared publications
Latest Publications
- Open Access
- 3 February 2026
- Published by MDPI AG in Microplastics
- Vol. 5 (1) , 25
Health Risks of Pristine and Leached Polystyrene Micro- and Nanoplastics: An In Vitro Study on Human Dental Pulp Stem Cells
The toxicity of micro- and nanoplastics in aquatic life is well documented, yet limited information is available on their effects in humans; moreover, most in vitro nanotoxicology studies rely on cancer cells. This study examined the effects of pristine and aged polystyrene micro- and nanoparticles on human dental pulp stem cells. While both particle sizes were internalized by the cells, primarily through endocytosis, they did not affect cell viability. In contrast, leachates from particles, aged for one month in culture medium, significantly reduced viability, indicating that toxicity arises from degradation byproducts rather than the particles themselves. Atomic force microscopy confirmed surface changes in aged plastics. Both particle sizes disorganized the cytoskeleton, leading to reduced actomyosin cortex integrity. Gene expression analysis revealed that leachates and aged particles activated inflammatory pathways, markedly increasing IL-8 and TGF-β1 expression, while also decreasing SOD levels associated with oxidative stress. No notable effects were observed on genes related to stemness or senescence. These results suggest that, while pristine micro- and nanoplastics may be relatively inert, their degradation products pose greater toxicological risks to human health. The findings highlight the importance of considering leachate toxicity in plastic pollution studies and demonstrate the value of stem cell-based models for evaluating the cellular and molecular impacts of environmental contaminants on human health.
- 3 February 2026
- Published by MDPI AG in Microplastics
- Vol. 5 (1) , 25
Open AccessHealth Risks of Pristine and Leached Polystyrene Micro- and Nanoplastics: An In Vitro Study on Human Dental Pulp Stem Cells
The toxicity of micro- and nanoplastics in aquatic life is well documented, yet limited information is available on their effects in humans; moreover, most in vitro nanotoxicology studies rely on cancer cells. This study examined the effects of pristine and aged polystyrene micro- and nanoparticles on human dental pulp stem cells. While both particle sizes were internalized by the cells, primarily through endocytosis, they did not affect cell viability. In contrast, leachates from particles, aged for one month in culture medium, significantly reduced viability, indicating that toxicity arises from degradation byproducts rather than the particles themselves. Atomic force microscopy confirmed surface changes in aged plastics. Both particle sizes disorganized the cytoskeleton, leading to reduced actomyosin cortex integrity. Gene expression analysis revealed that leachates and aged particles activated inflammatory pathways, markedly increasing IL-8 and TGF-β1 expression, while also decreasing SOD levels associated with oxidative stress. No notable effects were observed on genes related to stemness or senescence. These results suggest that, while pristine micro- and nanoplastics may be relatively inert, their degradation products pose greater toxicological risks to human health. The findings highlight the importance of considering leachate toxicity in plastic pollution studies and demonstrate the value of stem cell-based models for evaluating the cellular and molecular impacts of environmental contaminants on human health.
- Open Access
- 21 January 2026
- Published by IntechOpen
Epigenetics of Heart Development and Disease
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, accounting for approximately 31% of global mortality. Despite advances in diagnosis, prevention, and treatment, the prevalence of CVD continues to rise, highlighting that traditional risk factors (hypertension, diabetes, and dyslipidemia) do not fully explain disease susceptibility. Epigenetics, defined as heritable modifications of gene expression independent of DNA sequence changes, has emerged as a critical factor influencing cardiovascular health and development. This regulation involves dynamic changes in chromatin structure through chromatin remodeling and DNA and histone chemical modifications, as well as the regulatory functions of noncoding RNAs. Epigenetic mechanisms modulate gene expression programs essential for cardiovascular development and response to injury, linking environmental exposures to disease onset and progression. Epigenetic dysregulation has been implicated in heart failure (HF) pathogenesis, often exacerbated by comorbid conditions like diabetes. Understanding epigenetic contributions offers promising avenues for novel therapeutic strategies targeting these molecular pathways. This chapter focuses on the evolving role of epigenetics as a key nongenetic determinant of cardiac development and heart failure.
- 21 January 2026
- Published by IntechOpen
Open AccessEpigenetics of Heart Development and Disease
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, accounting for approximately 31% of global mortality. Despite advances in diagnosis, prevention, and treatment, the prevalence of CVD continues to rise, highlighting that traditional risk factors (hypertension, diabetes, and dyslipidemia) do not fully explain disease susceptibility. Epigenetics, defined as heritable modifications of gene expression independent of DNA sequence changes, has emerged as a critical factor influencing cardiovascular health and development. This regulation involves dynamic changes in chromatin structure through chromatin remodeling and DNA and histone chemical modifications, as well as the regulatory functions of noncoding RNAs. Epigenetic mechanisms modulate gene expression programs essential for cardiovascular development and response to injury, linking environmental exposures to disease onset and progression. Epigenetic dysregulation has been implicated in heart failure (HF) pathogenesis, often exacerbated by comorbid conditions like diabetes. Understanding epigenetic contributions offers promising avenues for novel therapeutic strategies targeting these molecular pathways. This chapter focuses on the evolving role of epigenetics as a key nongenetic determinant of cardiac development and heart failure.
- Open Access
- 10 October 2025
- Published by MDPI AG in Micromachines
- Vol. 16 (10) , 1150
Nanostructured Scaffold, Combined with Human Dental Pulp Stem Cell Secretome, Induces Vascularization in Medicinal Leech Model
As life expectancy continues to increase, age-related disorders are becoming more prevalent. Among these, vascular complications resulting from chronic inflammation are particularly concerning, as they impair angiogenesis and hinder tissue repair, both processes that heavily rely on a well-structured extracellular matrix (ECM). In this context, MicroMatrix® UBM Particulate, a skin substitute composed of collagen, laminin, and proteoglycans, appears to offer properties conducive to tissue regeneration. The aim of this study was to evaluate the regenerative potential of MicroMatrix® combined with the Secretome of human Dental Pulp Stem Cells (hDPSC-S), using the medicinal leech Hirudo verbana, a well-established model for studying wound healing, angiogenesis, and tissue regeneration. Adult leeches were injected with MicroMatrix® either suspended in FBS-free medium (CTRL) or supplemented with hDPSC-S. 1-week post-treatment, the animals were sacrificed and subjected to morphological and immunohistochemical analyses. Our findings revealed that MicroMatrix® successfully integrated into the leech body wall. Notably, when supplemented with hDPSC-S, there was a marked increase in cell infiltration, including telocytes and Hematopoietic Precursor Stem Cells, along with a significantly higher vessel density compared to CTRL. These results support the effectiveness of the cell-free device composed of MicroMatrix® and hDPSC-S, highlighting its potential as a promising strategy for regenerative therapies aimed at treating complex wounds with poor vascularization.
- 10 October 2025
- Published by MDPI AG in Micromachines
- Vol. 16 (10) , 1150
Open AccessNanostructured Scaffold, Combined with Human Dental Pulp Stem Cell Secretome, Induces Vascularization in Medicinal Leech Model
As life expectancy continues to increase, age-related disorders are becoming more prevalent. Among these, vascular complications resulting from chronic inflammation are particularly concerning, as they impair angiogenesis and hinder tissue repair, both processes that heavily rely on a well-structured extracellular matrix (ECM). In this context, MicroMatrix® UBM Particulate, a skin substitute composed of collagen, laminin, and proteoglycans, appears to offer properties conducive to tissue regeneration. The aim of this study was to evaluate the regenerative potential of MicroMatrix® combined with the Secretome of human Dental Pulp Stem Cells (hDPSC-S), using the medicinal leech Hirudo verbana, a well-established model for studying wound healing, angiogenesis, and tissue regeneration. Adult leeches were injected with MicroMatrix® either suspended in FBS-free medium (CTRL) or supplemented with hDPSC-S. 1-week post-treatment, the animals were sacrificed and subjected to morphological and immunohistochemical analyses. Our findings revealed that MicroMatrix® successfully integrated into the leech body wall. Notably, when supplemented with hDPSC-S, there was a marked increase in cell infiltration, including telocytes and Hematopoietic Precursor Stem Cells, along with a significantly higher vessel density compared to CTRL. These results support the effectiveness of the cell-free device composed of MicroMatrix® and hDPSC-S, highlighting its potential as a promising strategy for regenerative therapies aimed at treating complex wounds with poor vascularization.
- 9 May 2025
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 136 (10) , 1096-1098
Histone Methyltransferase SETD2: A Key Player in Cardiometabolic HFpEF
- 9 May 2025
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 136 (10) , 1096-1098
Histone Methyltransferase SETD2: A Key Player in Cardiometabolic HFpEF
- 29 September 2023
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 133 (8) , 687-703
Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis
BACKGROUND: Heart failure is typical in the elderly. Metabolic remodeling of cardiomyocytes underlies inexorable deterioration of cardiac function with aging: glycolysis increases at the expense of oxidative phosphorylation, causing an energy deficit contributing to impaired contractility. Better understanding of the mechanisms of this metabolic switching could be critical for reversing the condition. METHODS: To investigate the role of 3 histone modifications (H3K27ac, H3K27me3, and H3K4me1) in the metabolic remodeling occurring in the aging heart, we cross-compared epigenomic, transcriptomic, and metabolomic data from mice of different ages. In addition, the role of the transcriptional coactivator p300 (E1A-associated binding protein p300)/CBP (CREB binding protein) in cardiac aging was investigated using a specific inhibitor of this histone acetyltransferase enzyme. RESULTS: We report a set of species-conserved enhancers associated with transcriptional changes underlying age-related metabolic remodeling in cardiomyocytes. Activation of the enhancer region of Hk2 —a key glycolysis pathway gene—was fostered in old age–onset mouse heart by pseudohypoxia, wherein hypoxia-related genes are expressed under normal O 2 levels, via increased activity of P300/CBP. Pharmacological inhibition of this transcriptional coactivator before the onset of cardiac aging led to a more aerobic, less glycolytic, metabolic state, improved heart contractility, and overall blunting of cardiac decline. CONCLUSIONS: Taken together, our results suggest how epigenetic dysregulation of glycolysis pathway enhancers could potentially be targeted to treat heart failure in the elderly.
- 29 September 2023
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 133 (8) , 687-703
Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis
BACKGROUND: Heart failure is typical in the elderly. Metabolic remodeling of cardiomyocytes underlies inexorable deterioration of cardiac function with aging: glycolysis increases at the expense of oxidative phosphorylation, causing an energy deficit contributing to impaired contractility. Better understanding of the mechanisms of this metabolic switching could be critical for reversing the condition. METHODS: To investigate the role of 3 histone modifications (H3K27ac, H3K27me3, and H3K4me1) in the metabolic remodeling occurring in the aging heart, we cross-compared epigenomic, transcriptomic, and metabolomic data from mice of different ages. In addition, the role of the transcriptional coactivator p300 (E1A-associated binding protein p300)/CBP (CREB binding protein) in cardiac aging was investigated using a specific inhibitor of this histone acetyltransferase enzyme. RESULTS: We report a set of species-conserved enhancers associated with transcriptional changes underlying age-related metabolic remodeling in cardiomyocytes. Activation of the enhancer region of Hk2 —a key glycolysis pathway gene—was fostered in old age–onset mouse heart by pseudohypoxia, wherein hypoxia-related genes are expressed under normal O 2 levels, via increased activity of P300/CBP. Pharmacological inhibition of this transcriptional coactivator before the onset of cardiac aging led to a more aerobic, less glycolytic, metabolic state, improved heart contractility, and overall blunting of cardiac decline. CONCLUSIONS: Taken together, our results suggest how epigenetic dysregulation of glycolysis pathway enhancers could potentially be targeted to treat heart failure in the elderly.
- Open Access
- 2 September 2023
- Published by MDPI AG in Nanomaterials
- Vol. 13 (17) , 2479
Human Dental Pulp Mesenchymal Stem Cell-Derived Soluble Factors Combined with a Nanostructured Scaffold Support the Generation of a Vascular Network In Vivo
Among all strategies directed at developing new tools to support re-vascularization of damaged tissues, the use of pro-angiogenic soluble factors, derived from mesenchymal stem cells (MSCs), appears a promising approach for regenerative medicine. Here, we compared the feasibility of two devices, generated by coupling soluble factors of human dental pulp mesenchymal stem cells (DPSCs), with a nanostructured scaffold, to support angiogenesis once transplanted in mice. DPSCs were obtained from impacted wisdom tooth removal, usually considered surgical waste material. After 28 days, we verified the presence of active blood vessels inside the scaffold through optical and scansion electron microscopy. The mRNA expression of surface antigens related to macrophage polarization (CD68, CD80, CD86, CD163, CD206), as well as pro-angiogenic markers (CD31, CD34, CD105, Angpt1, Angpt2, CDH5) was evaluated by real-time PCR. Our results demonstrate the capability of DPSC–scaffold and DPSC soluble factors–scaffold to support angiogenesis, similarly to adipose stem cells, whereas the absence of blood vessels was found in the scaffold grafted alone. Our results provide evidence that DPSC-conditioned medium can be proposed as a cell-free preparation able to support angiogenesis, thus, providing a relevant tool to overcome the issues and restrictions associated with the use of cells.
- 2 September 2023
- Published by MDPI AG in Nanomaterials
- Vol. 13 (17) , 2479
Open AccessHuman Dental Pulp Mesenchymal Stem Cell-Derived Soluble Factors Combined with a Nanostructured Scaffold Support the Generation of a Vascular Network In Vivo
Among all strategies directed at developing new tools to support re-vascularization of damaged tissues, the use of pro-angiogenic soluble factors, derived from mesenchymal stem cells (MSCs), appears a promising approach for regenerative medicine. Here, we compared the feasibility of two devices, generated by coupling soluble factors of human dental pulp mesenchymal stem cells (DPSCs), with a nanostructured scaffold, to support angiogenesis once transplanted in mice. DPSCs were obtained from impacted wisdom tooth removal, usually considered surgical waste material. After 28 days, we verified the presence of active blood vessels inside the scaffold through optical and scansion electron microscopy. The mRNA expression of surface antigens related to macrophage polarization (CD68, CD80, CD86, CD163, CD206), as well as pro-angiogenic markers (CD31, CD34, CD105, Angpt1, Angpt2, CDH5) was evaluated by real-time PCR. Our results demonstrate the capability of DPSC–scaffold and DPSC soluble factors–scaffold to support angiogenesis, similarly to adipose stem cells, whereas the absence of blood vessels was found in the scaffold grafted alone. Our results provide evidence that DPSC-conditioned medium can be proposed as a cell-free preparation able to support angiogenesis, thus, providing a relevant tool to overcome the issues and restrictions associated with the use of cells.
- Open Access
- 26 July 2023
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 23 (19) , 9151-9159
Iron Oxide Nanoparticles with and without Cobalt Functionalization Provoke Changes in the Transcription Profile via Epigenetic Modulation of Enhancer Activity
Despite the progress in the field of nanotoxicology, much about the cellular mechanisms that mediate the adverse effects of nanoparticles (NPs) and, in particular, the possible role of epigenetics in nanotoxicity, remains to be clarified. Therefore, we studied the changes occurring in the genome-wide distribution of H3K27ac, H3K4me1, H3K9me2, and H3K27me3 histone modifications and compared them with the transcriptome after exposing NIH3T3 cells to iron-based magnetic NPs (i.e., Fe2O3 and Fe2O3@Co NPs). We found that the transcription response is mainly due to changes in the genomic distribution of H3K27ac that can modulate the activity of enhancers. We propose that alteration of the epigenetic landscape is a key mechanism in defining the gene expression program changes resulting in nanotoxicity. With this approach, it is possible to construct a data set of genomic regions that could be useful for defining toxicity in a manner that is more comprehensive than what is possible with the present toxicology assays.
- 26 July 2023
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 23 (19) , 9151-9159
Open AccessIron Oxide Nanoparticles with and without Cobalt Functionalization Provoke Changes in the Transcription Profile via Epigenetic Modulation of Enhancer Activity
Despite the progress in the field of nanotoxicology, much about the cellular mechanisms that mediate the adverse effects of nanoparticles (NPs) and, in particular, the possible role of epigenetics in nanotoxicity, remains to be clarified. Therefore, we studied the changes occurring in the genome-wide distribution of H3K27ac, H3K4me1, H3K9me2, and H3K27me3 histone modifications and compared them with the transcriptome after exposing NIH3T3 cells to iron-based magnetic NPs (i.e., Fe2O3 and Fe2O3@Co NPs). We found that the transcription response is mainly due to changes in the genomic distribution of H3K27ac that can modulate the activity of enhancers. We propose that alteration of the epigenetic landscape is a key mechanism in defining the gene expression program changes resulting in nanotoxicity. With this approach, it is possible to construct a data set of genomic regions that could be useful for defining toxicity in a manner that is more comprehensive than what is possible with the present toxicology assays.
- Open Access
- 5 July 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1123114
A chromEM-staining protocol optimized for cardiac tissue
Three-dimensional (3D) chromatin organization has a key role in defining the transcription program of cells during development. Its alteration is the cause of gene expression changes responsible for several diseases. Thus, we need new tools to study this aspect of gene expression regulation. To this end, ChromEM was recently developed: this is an electron-microscopy staining technique that selectively marks nuclear DNA without altering its structure and, thus, allows better visualization of 3D chromatin conformation. However, despite increasingly frequent application of this staining technique on cells, it has not yet been applied to visualize chromatin ultrastructure in tissues. Here, we provide a protocol to carry out ChromEM on myocardial tissue harvested from the left ventricles of C57BL/6J mice and use this in combination with transmission electron microscopy (TEM) to measure some morphological parameters of peripheral heterochromatin in cardiomyocytes. This protocol could also be used, in combination with electron tomography, to study 3D chromatin organization in cardiomyocytes in different aspects of heart pathobiology (e.g., heart development, cardiac aging, and heart failure) as well as help to set-up ChromEM in other tissues.
- 5 July 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1123114
Open AccessA chromEM-staining protocol optimized for cardiac tissue
Three-dimensional (3D) chromatin organization has a key role in defining the transcription program of cells during development. Its alteration is the cause of gene expression changes responsible for several diseases. Thus, we need new tools to study this aspect of gene expression regulation. To this end, ChromEM was recently developed: this is an electron-microscopy staining technique that selectively marks nuclear DNA without altering its structure and, thus, allows better visualization of 3D chromatin conformation. However, despite increasingly frequent application of this staining technique on cells, it has not yet been applied to visualize chromatin ultrastructure in tissues. Here, we provide a protocol to carry out ChromEM on myocardial tissue harvested from the left ventricles of C57BL/6J mice and use this in combination with transmission electron microscopy (TEM) to measure some morphological parameters of peripheral heterochromatin in cardiomyocytes. This protocol could also be used, in combination with electron tomography, to study 3D chromatin organization in cardiomyocytes in different aspects of heart pathobiology (e.g., heart development, cardiac aging, and heart failure) as well as help to set-up ChromEM in other tissues.
- Open Access
- 22 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 2205
Non-Coding RNAs in Cell-to-Cell Communication: Exploiting Physiological Mechanisms as Therapeutic Targets in Cardiovascular Pathologies
Cardiovascular disease, the leading cause of death worldwide, has been characterized at the molecular level by alterations in gene expression that contribute to the etiology of the disease. Such alterations have been shown to play a critical role in the development of atherosclerosis, cardiac remodeling, and age-related heart failure. Although much is now known about the cellular and molecular mechanisms in this context, the role of epigenetics in the onset of cardiovascular disease remains unclear. Epigenetics, a complex network of mechanisms that regulate gene expression independently of changes to the DNA sequence, has been highly implicated in the loss of homeostasis and the aberrant activation of a myriad of cellular pathways. More specifically, non-coding RNAs have been gaining much attention as epigenetic regulators of various pathologies. In this review, we will provide an overview of the ncRNAs involved in cell-to-cell communication in cardiovascular disease, namely atherosclerosis, cardiac remodeling, and cardiac ageing, and the potential use of epigenetic drugs as novel therapeutic targets.
- 22 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 2205
Open AccessNon-Coding RNAs in Cell-to-Cell Communication: Exploiting Physiological Mechanisms as Therapeutic Targets in Cardiovascular Pathologies
Cardiovascular disease, the leading cause of death worldwide, has been characterized at the molecular level by alterations in gene expression that contribute to the etiology of the disease. Such alterations have been shown to play a critical role in the development of atherosclerosis, cardiac remodeling, and age-related heart failure. Although much is now known about the cellular and molecular mechanisms in this context, the role of epigenetics in the onset of cardiovascular disease remains unclear. Epigenetics, a complex network of mechanisms that regulate gene expression independently of changes to the DNA sequence, has been highly implicated in the loss of homeostasis and the aberrant activation of a myriad of cellular pathways. More specifically, non-coding RNAs have been gaining much attention as epigenetic regulators of various pathologies. In this review, we will provide an overview of the ncRNAs involved in cell-to-cell communication in cardiovascular disease, namely atherosclerosis, cardiac remodeling, and cardiac ageing, and the potential use of epigenetic drugs as novel therapeutic targets.